RAJENDRA KUMAR SAWH MD NPI 1174595391

NPI Details

Rajendra Kumar Sawh, MD is an internal medicine in Lakeland, FL with 39 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Rajendra Kumar Sawh, MD NPI is 1174595391. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1600 LAKELAND HILLS BLVD
LAKELAND, FL
ZIP 33805
Phone: (863) 680-7000
Fax: (866) 264-8519

The NPI 1174595391 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Automated urinalysis test (HCPCS:81003)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Injection of drug or substance into vein (HCPCS:96374)
• Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram (HCPCS:J7644)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, ertapenem sodium, 500 mg (HCPCS:J1335)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of vaccine (HCPCS:90471)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) (HCPCS:90715)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Diagnostic exam of anus using an endoscope (HCPCS:46600)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less (HCPCS:12001)
• Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12002)
• Blood creatinine level (HCPCS:82565)
• Slings (HCPCS:A4565)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Complicated or multiple drainage of skin abscess (HCPCS:10061)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 2/2/2006 and was last updated on 11/27/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: